AcuImmune is a comprehensive source of immune assessment testing for research and non-GLP preclinical analysis. The company specializes in customizable immunoassays to identify cancer biomarkers, characterize drug candidate immunogenicity, and aid in allergy diagnosis. AcuImmune has also supported translational studies in gene therapy, cardiovascular and metabolic disorders, inflammation, and oncology. Scientists at AcuImmune offer 20 years of experience in the development of robust immunological assays­.